Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Hoffmann

Showing results (201-210 of 221) with videos related to

Pageof 23
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 28, 2020
Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγtChristian Gege, Michael Albers, Olaf Kinzel, et al.
Elife|August 8, 2023
Precision RNAi using synthetic shRNAmir target sitesThomas Hoffmann, Alexandra Hörmann, Maja Corcokovic, et al.
Elife|July 11, 2017
Synthetic lethality between the cohesin subunits <i>STAG1</i> and <i>STAG2</i> in diverse cancer contextsPetra van der Lelij, Simone Lieb, Julian Jude, et al.
American Journal of Hematology|July 7, 2022
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph<sup>+</sup> chronic myeloid leukemiaBarbara Peter, Gregor Eisenwort, Irina Sadovnik, et al.
Nature Biotechnology|March 7, 2017
Prediction of potent shRNAs with a sequential classification algorithmRaphael Pelossof, Lauren Fairchild, Chun-Hao Huang, et al.
Science (New York, N.Y.)|April 7, 2018
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axisMatthias Muhar, Anja Ebert, Tobias Neumann, et al.
Scandinavian Journal of Public Health|March 5, 2016
LIFESTAT - Living with statins: An interdisciplinary project on the use of statins as a cholesterol-lowering treatment and for cardiovascular risk reductionChrista Lykke Christensen, Jørn Wulff Helge, Allan Krasnik, et al.
Journal of Medicinal Chemistry|April 16, 2025
Identification of JNJ-61803534, a RORγt Inverse Agonist for the Treatment of PsoriasisOlaf Kinzel, Steven D Goldberg, Maxwell D Cummings, et al.
Oncoimmunology|July 3, 2015
Myeloid <i>STAT3</i> promotes formation of colitis-associated colorectal cancer in micePaulina Pathria, Dagmar Gotthardt, Michaela Prchal-Murphy, et al.
Journal of the International Academy of Periodontology|April 1, 2020
Proposal of a Clinical Endpoint for Periodontal Trials: The Treat-to-Target ApproachMagda Feres, Belen Retamal-Valdes, Marcelo Faveri, et al.
Pageof 23

Showing results (201-210 of 221) with videos related to

Sort By:
Pageof 23
Bioorganic & Medicinal Chemistry Letters|April 28, 2020
Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγtChristian Gege, Michael Albers, Olaf Kinzel, et al.
Elife|August 8, 2023
Precision RNAi using synthetic shRNAmir target sitesThomas Hoffmann, Alexandra Hörmann, Maja Corcokovic, et al.
Elife|July 11, 2017
Synthetic lethality between the cohesin subunits <i>STAG1</i> and <i>STAG2</i> in diverse cancer contextsPetra van der Lelij, Simone Lieb, Julian Jude, et al.
American Journal of Hematology|July 7, 2022
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph<sup>+</sup> chronic myeloid leukemiaBarbara Peter, Gregor Eisenwort, Irina Sadovnik, et al.
Nature Biotechnology|March 7, 2017
Prediction of potent shRNAs with a sequential classification algorithmRaphael Pelossof, Lauren Fairchild, Chun-Hao Huang, et al.
Science (New York, N.Y.)|April 7, 2018
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axisMatthias Muhar, Anja Ebert, Tobias Neumann, et al.
Scandinavian Journal of Public Health|March 5, 2016
LIFESTAT - Living with statins: An interdisciplinary project on the use of statins as a cholesterol-lowering treatment and for cardiovascular risk reductionChrista Lykke Christensen, Jørn Wulff Helge, Allan Krasnik, et al.
Journal of Medicinal Chemistry|April 16, 2025
Identification of JNJ-61803534, a RORγt Inverse Agonist for the Treatment of PsoriasisOlaf Kinzel, Steven D Goldberg, Maxwell D Cummings, et al.
Oncoimmunology|July 3, 2015
Myeloid <i>STAT3</i> promotes formation of colitis-associated colorectal cancer in micePaulina Pathria, Dagmar Gotthardt, Michaela Prchal-Murphy, et al.
Journal of the International Academy of Periodontology|April 1, 2020
Proposal of a Clinical Endpoint for Periodontal Trials: The Treat-to-Target ApproachMagda Feres, Belen Retamal-Valdes, Marcelo Faveri, et al.
Pageof 23